Literature DB >> 17385033

Screening for colorectal cancer in personnel of an academic medical center.

Zohar Levi1, Nechama Chorev, Negba Segal, Shlomit Plaut, Ilana Shemesh, Bracha Chadad, Ilana Murad, Galia Niv, Yaron Niv.   

Abstract

The colorectal cancer (CRC) screening program in Israel offers the average-risk population fecal occult blood tests from the age of 50 years. Compliance, however, is very low, reaching only 6% of eligible persons in 2005. Our aim in this study was to describe the results of an improved CRC screening program directed at the in-house staff of Beilinson Hospital. All employees of Beilinson Hospital over age 50 years were sent a letter explaining the new CRC screening program and an accompanying questionnaire. Responders who reported a family history of CRC or related cancers or symptoms were offered colonoscopy; the remainder were offered sigmoidoscopy or, if they preferred, colonoscopy. Two hundred twenty of the 888 candidates (24.7%) completed the questionnaire, of whom 144 (16.2%) agreed to further investigation. These included 90 of 105 patients with a positive questionnaire and 20 of 115 with a negative questionnaire who underwent colonoscopy and 34 of 115 with a negative questionnaire who underwent sigmoidoscopy. The colonoscopy group included 26 of the 30 patients (86.6%) with a positive family history. Early-stage CRC was diagnosed in three patients (1.36%), all with a positive questionnaire. There were no pathologic findings on sigmoidoscopy. The sensitivity, specificity, and positive and negative predictive values of the questionnaire for identifying subjects with CRC or advanced adenoma were 100.00%, 18.86%, 2.27%, and 100.00%, respectively. In conclusion, using hospital facilities, we initiated a unique CRC screening program for employees. Our method may be applicable in other medical centers for the detection of adenomas and CRCs in the early, curative stages.

Entities:  

Mesh:

Year:  2007        PMID: 17385033     DOI: 10.1007/s10620-006-9675-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  6 in total

1.  Report of the World Organization for Digestive Endoscopy Colorectal Cancer Screening Committee Meeting, Chicago, 2005.

Authors:  Paul Rozen
Journal:  Eur J Cancer Prev       Date:  2006-04       Impact factor: 2.497

2.  A national survey of primary care physicians' methods for screening for fecal occult blood.

Authors:  Marion R Nadel; Jean A Shapiro; Carrie N Klabunde; Laura C Seeff; Robert Uhler; Robert A Smith; David F Ransohoff
Journal:  Ann Intern Med       Date:  2005-01-18       Impact factor: 25.391

3.  Risk stratification for colon neoplasia: screening strategies using colonoscopy and computerized tomographic colonography.

Authors:  Otto S Lin; Richard A Kozarek; Drew B Schembre; Kamran Ayub; Michael Gluck; Nico Cantone; Maw-Soan Soon; Jason A Dominitz
Journal:  Gastroenterology       Date:  2006-10       Impact factor: 22.682

4.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

5.  Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Authors:  O Kronborg; C Fenger; J Olsen; O D Jørgensen; O Søndergaard
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

6.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

  6 in total
  1 in total

1.  Academic hospital staff compliance with a fecal immunochemical test-based colorectal cancer screening program.

Authors:  Georgia Vlachonikolou; Paraskevas Gkolfakis; Athanasios D Sioulas; Ioannis S Papanikolaou; Anastasia Melissaratou; Giannis-Aimant Moustafa; Eleni Xanthopoulou; Gerasimos Tsilimidos; Ioanna Tsironi; Paraskevas Filippidis; Chrysoula Malli; George D Dimitriadis; Konstantinos Triantafyllou
Journal:  World J Gastrointest Oncol       Date:  2016-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.